STOCK TITAN

Integra LifeSciences to Host Fourth Quarter and Full Year 2023 Financial Results Conference Call on February 28, 2024

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary
Integra LifeSciences Holdings Corporation (IART) is set to release its fourth quarter and full year 2023 financial results on February 28, 2024. The management team will host a conference call at 8:30 a.m. ET, with a live webcast available on the Investors section of the company's website. Participants can register for the call and access dial-in details. A webcast replay will also be available on the Investors section of the website.
Positive
  • None.
Negative
  • None.

PRINCETON, N.J., Feb. 07, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release fourth quarter and full year 2023 financial results on Wednesday, February 28, 2024, prior to the market open. In conjunction with the earnings release, Integra’s management team will host a conference call at 8:30 a.m. ET.

A live webcast will be available on the Investors section of the Company’s website at investor.integralife.com. For those planning to participate on the call, register here to receive dial-in details and an individual pin. While not required, joining 10 minutes before the event starts is recommended. A webcast replay of the conference call will be available on the Investors section of the Company’s website following the call.

About Integra LifeSciences

At Integra LifeSciences, we are driven by our purpose of restoring patients’ lives. We innovate treatment pathways to advance patient outcomes and set new standards of surgical, neurologic and regenerative care. We offer a comprehensive portfolio of high quality, leadership brands that include AmnioExcel®, Aurora®, Bactiseal®, BioD™, CerebroFlo®, CereLink® Certas® Plus, Codman®, CUSA®, Cytal®, DuraGen®, DuraSeal®, DuraSorb®, Gentrix®, ICP Express®, Integra®, Licox®, MAYFIELD®, MediHoney®, MicroFrance®, MicroMatrix®, NeuraGen®, NeuraWrap™, PriMatrix®, SurgiMend®, TCC-EZ® and VersaTru®. For the latest news and information about Integra and its products, please visit www.integralife.com.

Investor Relations:
Chris Ward
(609) 772-7736
chris.ward@integralife.com   

Media Contact:
Laurene Isip
(609) 208-8121
laurene.isip@integralife.com


FAQ

When will Integra LifeSciences Holdings Corporation release its fourth quarter and full year 2023 financial results?

Integra LifeSciences Holdings Corporation will release its fourth quarter and full year 2023 financial results on February 28, 2024.

What time will the conference call for the earnings release take place?

The conference call for the earnings release will take place at 8:30 a.m. ET.

Where can I access the live webcast for the earnings release?

The live webcast for the earnings release will be available on the Investors section of the Company’s website at investor.integralife.com.

How can I register to participate in the conference call?

Participants can register for the conference call and receive dial-in details by visiting the Company’s website.

Will there be a webcast replay available for the conference call?

Yes, a webcast replay of the conference call will be available on the Investors section of the Company’s website following the call.

Integra LifeSciences Holdings

NASDAQ:IART

IART Rankings

IART Latest News

IART Stock Data

1.70B
74.67M
3.21%
93.29%
5.31%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States of America
PRINCETON